Vimarsana
Biggest News Aggregation in the World

Assay Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Assay Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Assay Services Today - Breaking & Trending Today

Chrysos revenue to fall short of guidance despite rising international sales - Vimarsana News

Chrysos revenue to fall short of guidance despite rising international sales

Assay specialist working to mitigate customer “site-readiness” challenges

Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research - Vimarsana News

Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research

 Strategic partnership expands Biognosys’ services to include Alamar’s NULISA assays as well as joint scientific research in biofluid-based proteomicsComplementary value of Biognosys’ DIA-MS unbiased proteomics platform and Alamar’s game-changing immunoassay platforms to be presented at...

Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research - Vimarsana News

Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research

/PRNewswire/ -- Biognosys, a global leader in mass spectrometry-based proteomics, and Alamar Biosciences, Inc., a company powering precision proteomics to...

Reporter Assay Services in 2023 - News Reporter - Vimarsana News

Reporter Assay Services in 2023 - News Reporter

This article explores the role of reporter assays in 2023, highlighting their significant impact on biomedical research and their potential to drive advancements in the field.

BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT - Vimarsana News

BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the expansion of its Advanced Cell Diagnostics (ACD)-branded RNAscope™ in situ...